« Continue Browsing

Article Preview

FDA: Medtronic brain stimulator missed study goal

Published 03/10/2010, Associated Press

The Food and Drug Administration said today a nerve stimulating implant from Minneapolis-based Medtronic failed to significantly reduce seizures in epilepsy patients. The stock was trading down this morning on the NYSE.

Word count: 368

Log In

The full article is available to newspaper subscribers. If you are a subscriber please log in to continue reading.


Are you a newspaper subscriber but you don't have a Digital Access account yet? Click here to set one up. You will need your subscription account number and phone number.

Not sure if you have an account? Email us at subscriberservices@forumcomm.com and we can help you.

Reset Your Password

Please enter your full e-mail address. We will e-mail you a temporary password.